336 related articles for article (PubMed ID: 9089955)
1. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
Montefiori DC
Springer Semin Immunopathol; 1997; 18(3):371-90. PubMed ID: 9089955
[No Abstract] [Full Text] [Related]
2. Complement dependent trapping of infectious HIV in human lymphoid tissues.
Bánki Z; Kacani L; Rusert P; Pruenster M; Wilflingseder D; Falkensammer B; Stellbrink HJ; van Lunzen J; Trkola A; Dierich MP; Stoiber H
AIDS; 2005 Mar; 19(5):481-6. PubMed ID: 15764853
[TBL] [Abstract][Full Text] [Related]
3. Antibody-based HIV-1 vaccines: recent developments and future directions.
Montefiori D; Sattentau Q; Flores J; Esparza J; Mascola J;
PLoS Med; 2007 Dec; 4(12):e348. PubMed ID: 18052607
[TBL] [Abstract][Full Text] [Related]
4. Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients.
Knuchel MC; Speck RF; Schlaepfer E; Kuster H; Ott P; Günthard HF; Opravil M; Cone RW; Weber R
AIDS; 2000 Dec; 14(17):2661-9. PubMed ID: 11125884
[TBL] [Abstract][Full Text] [Related]
5. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
Willey S; Aasa-Chapman MM; O'Farrell S; Pellegrino P; Williams I; Weiss RA; Neil SJ
Retrovirology; 2011 Mar; 8():16. PubMed ID: 21401915
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus. Trapped but still dangerous.
Schrager LK; Fauci AS
Nature; 1995 Oct; 377(6551):680-1. PubMed ID: 7477256
[No Abstract] [Full Text] [Related]
7. Complement, Fc receptors and antibodies: a Trojan horse in HIV infection?
Stoiber H
Curr Opin HIV AIDS; 2009 Sep; 4(5):394-9. PubMed ID: 20048703
[TBL] [Abstract][Full Text] [Related]
8. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro.
Tóth FD; Mosborg-Petersen P; Kiss J; Aboagye-Mathiesen G; Zdravkovic M; Hager H; Aranyosi J; Lampé L; Ebbesen P
Clin Exp Immunol; 1994 Jun; 96(3):389-94. PubMed ID: 8004808
[TBL] [Abstract][Full Text] [Related]
10. Complement-HIV interactions during all steps of viral pathogenesis.
Stoiber H; Banki Z; Wilflingseder D; Dierich MP
Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
[TBL] [Abstract][Full Text] [Related]
11. Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment.
Hlavacek WS; Percus JK; Percus OE; Perelson AS; Wofsy C
Math Biosci; 2002 Apr; 176(2):185-202. PubMed ID: 11916508
[TBL] [Abstract][Full Text] [Related]
12. Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
[TBL] [Abstract][Full Text] [Related]
13. New perspectives on HIV pathogenesis. Viral replication is continuous throughout the course of disease.
J Assoc Nurses AIDS Care; 1995; 6(4):26-7. PubMed ID: 7495989
[No Abstract] [Full Text] [Related]
14. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.
Jassoy C; Walker BD
Springer Semin Immunopathol; 1997; 18(3):341-54. PubMed ID: 9089953
[No Abstract] [Full Text] [Related]
15. Enhancing antibodies in HIV infection.
Füst G
Parasitology; 1997; 115 Suppl():S127-40. PubMed ID: 9571698
[TBL] [Abstract][Full Text] [Related]
16. Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV.
Boyer V; Delibrias C; Noraz N; Fischer E; Kazatchkine MD; Desgranges C
Scand J Immunol; 1992 Dec; 36(6):879-83. PubMed ID: 1281336
[TBL] [Abstract][Full Text] [Related]
17. Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infection.
Sciaranghella G; Tong N; Mahan AE; Suscovich TJ; Alter G
AIDS; 2013 Jan; 27(2):175-80. PubMed ID: 23135171
[TBL] [Abstract][Full Text] [Related]
18. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H
J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
20. HIV and human complement: mechanisms of interaction and biological implication.
Dierich MP; Ebenbichler CF; Marschang P; Füst G; Thielens NM; Arlaud GJ
Immunol Today; 1993 Sep; 14(9):435-40. PubMed ID: 8216721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
